Establishment Labs Holdings (ESTA) Gross Margin (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Gross Margin of 70.7% in Q1 2026, little changed quarter-over-quarter from 70.46% in Q4 2025, and up 350.0% on a YoY basis from 15.71% in Q1 2025.
Establishment Labs Holdings (ESTA) Gross Margin (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Gross Margin history runs 10 years deep, the most recent figure standing at 70.7% for Q1 2026.
- In Q1 2026, Gross Margin rose 350.0% year-over-year to 70.7%; the TTM figure through Mar 2026 stood at 70.06% (up 371.0% YoY), while the FY2025 annual figure was 69.32%, up 335.0% from the prior year.
- Gross Margin was 70.7% for Q1 2026 at Establishment Labs Holdings, roughly flat from 70.46% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 70.7% in Q1 2026 to a low of 62.32% in Q2 2023.
- Historically, Gross Margin has averaged 66.74% across 5 years, with a median of 66.65% in 2022.
- The sharpest annual moves came in 2023 and 2025: Gross Margin slumped 434 bps in 2023, then jumped 616 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 64.28% in 2022, then gained by 1 bps to 65.22% in 2023, then grew by 5 bps to 68.5% in 2024, then grew by 3 bps to 70.46% in 2025, then climbed by 0 bps to 70.7% in 2026.
- The last three Gross Margin figures came in at 70.7% (Q1 2026), 70.46% (Q4 2025), and 70.09% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | 70.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.70% |
| Dec 31, 2025 | 70.46% |
| Sep 30, 2025 | 70.09% |
| Jun 30, 2025 | 68.76% |
| Mar 31, 2025 | 67.21% |
| Dec 31, 2024 | 68.50% |
| Sep 30, 2024 | 63.93% |
| Jun 30, 2024 | 65.59% |
| Mar 31, 2024 | 65.60% |
| Dec 31, 2023 | 65.22% |
| Sep 30, 2023 | 67.66% |
| Jun 30, 2023 | 62.32% |
| Mar 31, 2023 | 64.65% |
| Dec 31, 2022 | 64.28% |
| Sep 30, 2022 | 68.09% |
| Jun 30, 2022 | 66.65% |
| Mar 31, 2022 | 64.85% |
| Dec 31, 2021 | 68.60% |
| Sep 30, 2021 | 67.56% |
| Jun 30, 2021 | 67.10% |